Company Announcement AbbVie Inc. files complaint against Genmab in the U.S. District Court for the Western District of Washington (Seattle) ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Danish biotech (Nasdaq: GMAB) on Saturday revealed that US pharma major (AbbVie (NYSE: ABBV) has filed a complaint in the US ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

AbbVie's Elahere maintains strong efficacy in the Phase 3 MIRASOL trial for ovarian cancer, with durable survival benefits ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other dividend stocks. Dividend stocks have taken a backseat in the market as technology and AI ...

AbbVie Inc . (NYSE:ABBV) Executive Chairman Richard A. Gonzalez has sold a significant number of shares in the pharmaceutical ...

NORTH CHICAGO, Ill. - AbbVie (NYSE: NYSE:ABBV) has reported positive results from its Phase 2 PICCOLO trial, which evaluated the... ByInvesting.com • Jun 06, 2024 AbbVie Announces Positive ...